169 related articles for article (PubMed ID: 34732618)
21. Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia.
Potter N; Jones L; Blair H; Strehl S; Harrison CJ; Greaves M; Kearney L; Russell LJ
Leukemia; 2019 Apr; 33(4):893-904. PubMed ID: 30487598
[TBL] [Abstract][Full Text] [Related]
22. The prognostic significance of
Wang J; Sun K; Chen WM; Wang X; Li LD; Hao Y; Xu N; Jiang H; Xu LP; Wang Y; Zhang XH; Huang XJ; Jiang Q; Qin YZ
Leuk Lymphoma; 2023 Mar; 64(3):698-706. PubMed ID: 36642937
[TBL] [Abstract][Full Text] [Related]
23. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
Tigay JH
J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
[TBL] [Abstract][Full Text] [Related]
24. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan.
Asai D; Imamura T; Suenobu S; Saito A; Hasegawa D; Deguchi T; Hashii Y; Matsumoto K; Kawasaki H; Hori H; Iguchi A; Kosaka Y; Kato K; Horibe K; Yumura-Yagi K; Hara J; Oda M;
Cancer Med; 2013 Jun; 2(3):412-9. PubMed ID: 23930217
[TBL] [Abstract][Full Text] [Related]
25. CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities.
Chiaretti S; Brugnoletti F; Messina M; Paoloni F; Fedullo AL; Piciocchi A; Elia L; Vitale A; Mauro E; Ferrara F; De Fabritiis P; Luppi M; Ronco F; De Propris MS; Raponi S; Kronnie GT; Vignetti M; Guarini A; Foà R
Leuk Res; 2016 Feb; 41():36-42. PubMed ID: 26754556
[TBL] [Abstract][Full Text] [Related]
26. Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia.
Palmi C; Vendramini E; Silvestri D; Longinotti G; Frison D; Cario G; Shochat C; Stanulla M; Rossi V; Di Meglio AM; Villa T; Giarin E; Fazio G; Leszl A; Schrappe M; Basso G; Biondi A; Izraeli S; Conter V; Valsecchi MG; Cazzaniga G; Te Kronnie G
Leukemia; 2012 Oct; 26(10):2245-53. PubMed ID: 22484421
[TBL] [Abstract][Full Text] [Related]
27. Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.
Li Z; Chang TC; Junco JJ; Devidas M; Li Y; Yang W; Huang X; Hedges DJ; Cheng Z; Shago M; Carroll AJ; Heerema NA; Gastier-Foster J; Wood BL; Borowitz MJ; Sanclemente L; Raetz EA; Hunger SP; Feingold E; Rosser TC; Sherman SL; Loh ML; Mullighan CG; Yu J; Wu G; Lupo PJ; Rabin KR; Yang JJ
Blood; 2023 Jul; 142(2):172-184. PubMed ID: 37001051
[TBL] [Abstract][Full Text] [Related]
28. High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia.
Juárez-Velázquez MDR; Moreno-Lorenzana DL; Martínez Anaya DA; Hernández Monterde EA; Aguilar-Hernández MM; Reyes-León A; Chávez-González MA; López Santiago N; Zapata Tarrés M; Juárez Villegas L; Rivera Sánchez N; Soto Lerma O; Vega-Vega L; Rivera Luna R; Pérez-Vera P
Cytokine; 2022 Jul; 155():155896. PubMed ID: 35537330
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
Schmäh J; Fedders B; Panzer-Grümayer R; Fischer S; Zimmermann M; Dagdan E; Bens S; Schewe D; Moericke A; Alten J; Bleckmann K; Siebert R; Schrappe M; Stanulla M; Cario G
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371317
[TBL] [Abstract][Full Text] [Related]
30. Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol.
Patrick K; Wade R; Goulden N; Rowntree C; Hough R; Moorman AV; Mitchell CD; Vora A
Br J Haematol; 2014 May; 165(4):552-5. PubMed ID: 24428704
[TBL] [Abstract][Full Text] [Related]
31. Suspicions regarding the genetic inheritance of acute lymphoblastic leukemia in patients with down syndrome.
Behluli E; Nuhii N; Liehr T; Temaj G
J Mother Child; 2022 Mar; 26(1):104-110. PubMed ID: 35853737
[TBL] [Abstract][Full Text] [Related]
32. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
Brown AL; de Smith AJ; Gant VU; Yang W; Scheurer ME; Walsh KM; Chernus JM; Kallsen NA; Peyton SA; Davies GE; Ehli EA; Winick N; Heerema NA; Carroll AJ; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Feingold E; Devidas M; Barcellos LF; Hansen HM; Morimoto L; Kang AY; Smirnov I; Healy J; Laverdière C; Sinnett D; Taub JW; Birch JM; Thompson P; Spector LG; Pombo-de-Oliveira MS; DeWan AT; Mullighan CG; Hunger SP; Pui CH; Loh ML; Zwick ME; Metayer C; Ma X; Mueller BA; Sherman SL; Wiemels JL; Relling MV; Yang JJ; Lupo PJ; Rabin KR
Blood; 2019 Oct; 134(15):1227-1237. PubMed ID: 31350265
[TBL] [Abstract][Full Text] [Related]
33. Hematological disorders and leukemia in children with Down syndrome.
Bruwier A; Chantrain CF
Eur J Pediatr; 2012 Sep; 171(9):1301-7. PubMed ID: 22113227
[TBL] [Abstract][Full Text] [Related]
34. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S
Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401
[TBL] [Abstract][Full Text] [Related]
35. Array comparative genome hybridization analysis of acute lymphoblastic leukaemia and acute megakaryoblastic leukaemia in patients with Down syndrome.
Lo KC; Chalker J; Strehl S; Neat M; Smith O; Dastugue N; Kearney L; Izraeli S; Kempski H; Cowell JK
Br J Haematol; 2008 Sep; 142(6):934-45. PubMed ID: 18557744
[TBL] [Abstract][Full Text] [Related]
36. Outcome and Prognostic Factors for
Lee JW; Kim SK; Jang PS; Chung NG; Jeong DC; Kim M; Cho B; Kim HK
Cancer Res Treat; 2017 Apr; 49(2):446-453. PubMed ID: 27506214
[TBL] [Abstract][Full Text] [Related]
37. Integrated genetic and epigenetic analysis revealed heterogeneity of acute lymphoblastic leukemia in Down syndrome.
Kubota Y; Uryu K; Ito T; Seki M; Kawai T; Isobe T; Kumagai T; Toki T; Yoshida K; Suzuki H; Kataoka K; Shiraishi Y; Chiba K; Tanaka H; Ohki K; Kiyokawa N; Kagawa J; Miyano S; Oka A; Hayashi Y; Ogawa S; Terui K; Sato A; Hata K; Ito E; Takita J
Cancer Sci; 2019 Oct; 110(10):3358-3367. PubMed ID: 31385395
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries.
Lundin C; Forestier E; Klarskov Andersen M; Autio K; Barbany G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Johansson B; ; ;
J Hematol Oncol; 2014 Apr; 7():32. PubMed ID: 24726034
[TBL] [Abstract][Full Text] [Related]
39. Philadelphia chromosome-positive acute lymphoblastic leukemia and Down syndrome.
Tamaura M; Iwasaki F; Yokosuka T; Fukuda K; Hamonoue S; Goto H
Pediatr Int; 2016 Aug; 58(8):794-7. PubMed ID: 27325175
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia.
Gaikwad A; Rye CL; Devidas M; Heerema NA; Carroll AJ; Izraeli S; Plon SE; Basso G; Pession A; Rabin KR
Br J Haematol; 2009 Mar; 144(6):930-2. PubMed ID: 19120350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
